Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells

Journal of Infectious Diseases

Volumn 183, Issue 7, 2001, Pages 1055-1062

  Montemurro, Pasqualina ^a   Barbuti, Giovanna ^a   Dundon, William G ^b   Del Giudice, Giuseppe ^c   Rappuoli, Rino ^c   Colucci, Mario ^a   De Rinaldis, Pietro ^a   Montecucco, Cesare ^b   Semeraro, Nicola ^a   Papini, Emanuele ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c CHIRON VACCINES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBOPLASTIN; UROKINASE; VIRULENCE FACTOR;

ARTICLE; BACTERIUM MUTANT; DOSE TIME EFFECT RELATION; GRANULOMATOUS INFLAMMATION; HELICOBACTER PYLORI; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA ANALYSIS;

BACTERIAL PROTEINS; BLOTTING, NORTHERN; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOMATOUS DISEASE, CHRONIC; HELICOBACTER PYLORI; HUMANS; LEUKOCYTES, MONONUCLEAR; MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 2; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035312988     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319280     Document Type: Article

References (50)

1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
2. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia
3. Helicobacter pylori gastritis, peptic ulcer, and gastric cancer: Clinical and molecular aspects
4. Helicobacter pylori infection and gastric lymphoma
5. Helicobacter pylori infection and early onset myocardial infarction: Case-control and sibling pairs study
6. Helicobacter pylori infection: A risk factor for ischaemic cerebrovascular disease and carotid atheroma
7. Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage
8. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
9. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
10. Helicobacter pylori virulence and genetic geography
11. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells
12. Modulation of Helicobacter pylori-induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue
13. -Helicobacter pylori
14. Multiple genes in the left hand of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells
15. Increased COX-2, but not COX-1, mRNA expression in Helicobacter pylori gastritis
16. Molecular and cellular activities of Helicobacter pylori pathogenic factors
17. Characterization of a Helicobacter pylori neutrophil-activating protein
18. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure
19. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary, mucin
20. Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori
21. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor
22. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa
23. The structural basis of function of the TF-VIIa complex in the cellular initiation of coagulation
24. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation
25. Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes
26. Regulation of the tissue factor gene
27. Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors
28. Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes: Correlation with production of the protein
29. Tissue factor in health and disease
30. The role of inflammatory cells and their proteases in extravascular fibrinolysis
31. The unstable atherosclerotic plaque: Clinical significance and therapeutic intervention
32. Effect of Helicobacter pylori lipopolysaccharide (LPS) and LPS derivatives on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cells
33. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria
34. Isolation of lymphocytes, granulocytes and macrophages
35. Inhibitory effect of retinoids on the generation of procoagulant activity by blood mononuclear phagocytes
36. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites
37. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells
38. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor-1 (PAI-I) in the inhibition of clot lysis
39. Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis
40. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
41. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity
42. Biological and clinical aspects of plasminogen activator inhibitor type 2
43. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B
44. 4-Hydroxynonenal prevents NF-κB activation and tumor necrosis factor expression by inhibiting IκB phosphorylation and subsequent proteolysis
45. Monocyte tissue factor induction by lipopolysaccharide (LPS): Dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein
46. Enhancement of generation of monocyte tissue thromboplastin by bacterial phagocytosis: Possible pathway for fibrin formation on infected vegetations in bacterial endocarditis
47. Monocytes upregulate endothelial cell expression of tissue factor: A role for cell-cell contact and cross-talk
48. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro
49. Tissue factor in the pathogenesis of atherosclerosis
50. Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients